Schrödinger, Inc. (SDGR)
$25.89-0.08%Close
BUYCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.9B
- Beta
- 1.62
- P/E (TTM)
- -34.99
- Short % float
- 17.57%
- Days to cover
- 3.1
- SI change
- -9.3%
- 1W
- -10.42%
- 1M
- +24.77%
- vs SPY 1W
- -10.28%
- vs SPY 1M
- +22.27%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 2
- VALUE
- 7
- GROWTH
- 20
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-9.8%
REV YoY-
ROE-16.4%
EPS YoY-
ROA-8.5%
GROSS57
OP-59
NET-21
[VALUATION]
P/E TTM-34.99
P/E FWD-
SECTOR PE48.16
INDUSTRY PE45.05
P/B5.88
P/FCF-
EV/EBITDA-38.09
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E32.83
ALTMAN Z-
CURR RATIO2.71
ND/EBITDA-
BETA1.62
Company news
FAQ
- What is LOPJLB’s current signal on SDGR?
- LOPJLB’s latest quantitative signal on Schrödinger, Inc. (SDGR) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is SDGR in?
- Schrödinger, Inc. (SDGR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Schrödinger, Inc. (SDGR) do?
- Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform…